These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9229185)

  • 21. Calciotropic and phosphaturic hormones in heart failure.
    Zittermann A; Ernst JB
    Nutr Metab Cardiovasc Dis; 2016 Nov; 26(11):971-979. PubMed ID: 27493144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Theophylline, a methylxanthine drug induces osteopenia and alters calciotropic hormones, and prophylactic vitamin D treatment protects against these changes in rats.
    Pal S; Khan K; China SP; Mittal M; Porwal K; Shrivastava R; Taneja I; Hossain Z; Mandalapu D; Gayen JR; Wahajuddin M; Sharma VL; Trivedi AK; Sanyal S; Bhadauria S; Godbole MM; Gupta SK; Chattopadhyay N
    Toxicol Appl Pharmacol; 2016 Mar; 295():12-25. PubMed ID: 26851681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantation.
    Corey RL; Whitaker MD; Crowell MD; Keddis MT; Aqel B; Balan V; Byrne T; Carey E; Douglas DD; Harrison ME; Vargas HE; Rakela J
    Clin Transplant; 2014 May; 28(5):579-84. PubMed ID: 24628047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alcohol and bone disease.
    Rico H
    Alcohol Alcohol; 1990; 25(4):345-52. PubMed ID: 2222569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary hyperparathyroidism in primary osteoporosis and osteopenia: optimizing calcium and vitamin D intakes to levels recommended by expert panels may not be sufficient for correction.
    Yendt ER; Kovacs KA; Jones G
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):855-63. PubMed ID: 18419790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
    Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ
    J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calciotropic hormones and nephrolithiasis.
    D'Angelo A; Calò L; Cantaro S; Giannini S
    Miner Electrolyte Metab; 1997; 23(3-6):269-72. PubMed ID: 9387131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calciotropic hormones and bone markers in the elderly.
    Gallagher JC; Kinyamu HK; Fowler SE; Dawson-Hughes B; Dalsky GP; Sherman SS
    J Bone Miner Res; 1998 Mar; 13(3):475-82. PubMed ID: 9525348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TSH prevents bone resorption and with calcitriol synergistically stimulates bone formation in rats with low levels of calciotropic hormones.
    Dumic-Cule I; Draca N; Luetic AT; Jezek D; Rogic D; Grgurevic L; Vukicevic S
    Horm Metab Res; 2014 May; 46(5):305-12. PubMed ID: 24446158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic interventions in osteoporosis.
    Sutcliffe A
    Nurs Times; 2002 Mar 7-13; 98(10):52-4. PubMed ID: 11921627
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome.
    Panidis D; Balaris C; Farmakiotis D; Rousso D; Kourtis A; Balaris V; Katsikis I; Zournatzi V; Diamanti-Kandarakis E
    Clin Chem; 2005 Sep; 51(9):1691-7. PubMed ID: 16037412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D, parathyroid hormone, and bone mineral density status in kidney transplant recipients.
    Savaj S; Ghods FJ
    Iran J Kidney Dis; 2012 Jul; 6(4):295-9. PubMed ID: 22797100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurements of bone mineral density. Mineral density in metabolic bone disease.
    Fischer M; Raue F
    Q J Nucl Med; 1999 Sep; 43(3):233-40. PubMed ID: 10568139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic investigation for evaluation of calcium metabolism and parathyroid function.
    Cioppi F; Falchetti A; Masi L; Brandi ML
    J Endocrinol Invest; 2003; 26(7 Suppl):83-91. PubMed ID: 14604070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Posterior urethral valves: Metabolic consequences in a cohort of patients.
    Sarhan O; Nakshabandi Z; Alghanbar M; Alotay A; Sherif I; Whitehead C; El-Husseini A
    J Pediatr Urol; 2015 Aug; 11(4):216.e1-6. PubMed ID: 26096436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic osteopenia: pathophysiology and clinical aspects.
    Seino Y; Ishida H
    Diabetes Metab Rev; 1995 Apr; 11(1):21-35. PubMed ID: 7600905
    [No Abstract]   [Full Text] [Related]  

  • 39. Vitamin D status affects serum parathyroid hormone concentrations during winter in female adolescents: associations with forearm bone mineral density.
    Outila TA; Kärkkäinen MU; Lamberg-Allardt CJ
    Am J Clin Nutr; 2001 Aug; 74(2):206-10. PubMed ID: 11470722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic procedures in primary and secondary hyperparathyroidism or in hypercalcemia].
    Hey D; Schultis K
    Med Welt; 1969 Nov; 48():2655-7. PubMed ID: 5386517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.